Dokter lulus dari Sekolah Kedokteran Cerrahpaşa, Universitas Istanbul pada tahun 2000 dan menyelesaikan residensi di bidang Penyakit Dalam di Universitas Ankara pada tahun 2004, memperoleh gelar Internis. Dengan karier akademis yang produktif, dokter telah menyumbangkan 19 makalah internasional, 6 makalah lokal, dan mempresentasikan di 25 kongres lokal dan internasional. Dokter menerima Penghargaan Presentasi Verbal Terbaik dan Poster Terbaik di Kongres Kanker Sistem Gastrointestinal Internasional ke-7.<\/p>
Spesialisasi dalam prosedur endoskopi lanjutan, dokter berfokus pada perawatan seperti POEM untuk akalasia, ESD untuk kanker gastrointestinal tahap awal, ERCP untuk perawatan saluran empedu, Z-POEM untuk Divertikulum Zenker, dan G-POEM untuk gastroparesis.<\/p>
Dokter adalah seorang ahli onkologi dan ahli bedah umum berpengalaman dengan lebih dari 25 tahun pengalaman, yang mengkhususkan diri dalam perawatan kanker dan transplantasi organ. Diakui atas kontribusi signifikan di bidang ini, dokter telah menerima banyak penghargaan, termasuk AACR Scholar-in-Training Award dan Sertifikat Prestasi Luar Biasa dalam Transplantasi Hati. Dokter adalah anggota aktif dari beberapa asosiasi bergengsi, termasuk American Society of Breast Cancer dan Surgical Oncology Association, di mana mereka menjabat sebagai anggota Dewan Direksi.<\/p>
Dokter memiliki gelar M.Sc dari Fakultas Kedokteran, Universitas Çukurova, dan menyelesaikan Ph.D./Spesialisasi dalam Bedah Umum di Rumah Sakit Pelatihan dan Penelitian Ankara Numune.<\/p>
Chronic hepatitis B is not currently curable but is highly manageable through viral suppression. Turkish JCI-accredited hospitals provide antiviral protocols using Tenofovir or Entecavir. These therapies reduce viral load to prevent cirrhosis and liver cancer while maintaining long-term liver function.
Bookimed Expert Insight: Turkey's infrastructure is built for high-volume liver care. Medipol Mega University Hospital serves over 1,000,000 patients annually. This massive scale ensures doctors have extensive experience managing complex viral loads. Choosing a multi-specialty center with 70+ departments allows for faster coordination if liver complications arise.
Patient Consensus: Patients emphasize that long-term monitoring and regular blood tests are the most critical parts of the journey. Many note that the emotional relief of lowering their viral load is as important as the physical treatment.
Top Turkish hospitals for Hepatitis B treatment include Medipol Mega University Hospital, Memorial Şişli Hospital, and Anadolu Medical Center. These JCI-accredited facilities offer specialized gastroenterology and infectious disease departments. They provide essential long-term antiviral therapy, viral load monitoring, and advanced liver fibrosis staging.
Bookimed Expert Insight: Patients seeking HBV care should prioritize hospitals with high-volume organ transplant departments, like Memorial Şişli or Medipol. These centers possess the most advanced hepatology infrastructure. They often have more experience managing complex liver damage. This expertise ensures precise monitoring even if you do not require surgery.
Patient Consensus: Patients value doctors who emphasize long-term monitoring over immediate procedures. They note that choosing a major teaching hospital ensures more thorough liver enzyme and viral load tracking.
Chronic hepatitis B management requires suppression of the virus through long-term antiviral medication and regular liver monitoring. Turkish centers focus on using high-potency drugs like entecavir or tenofovir. Lifelong surveillance every 6 to 12 months is necessary to maintain a 99% survival rate by preventing cirrhosis.
Bookimed Expert Insight: Turkish JCI-accredited hospitals like Memorial Şişli and Anadolu Medical Center offer integrated oncology and transplant units. This infrastructure is vital because chronic management occasionally transitions into complex care. While many clinics serve thousands, these specific centers maintain 90% success rates for high-risk liver procedures.
Patient Consensus: Patients emphasize that staying with a consistent specialist clinic in Turkey is crucial for long-term tracking. They note that consistent medication adherence is vital to avoid dangerous viral rebounds or liver flare-ups.
The first visit for hepatitis B focuses on status confirmation and liver health assessment. Patients meet with a gastroenterologist or infectious disease specialist at JCI-accredited Turkish hospitals. The evaluation includes viral load testing, liver enzyme analysis, and non-invasive imaging like transient elastography to determine if immediate medication is necessary.
Bookimed Expert Insight: Turkish oncology and hepatology centers like Anadolu Medical Center benefit from high patient volumes. They serve over 65,000 patients annually. This massive data set allows specialists to differentiate between immune-active and inactive hepatitis B more accurately. High-volume clinics often provide more reliable long-term monitoring schedules due to their extensive experience with international case variations.
Patient Consensus: Patients note that the first visit is very test-heavy. They emphasize bringing previous lab records to help doctors track the virus's stability over time.
Liver transplantation is a primary treatment for HBV-related end-stage liver disease in Turkey. Chronic Hepatitis B causes over 35% of all liver transplants in the country. Turkish JCI-accredited centers perform living and cadaveric surgeries with success rates reaching 90% for organ transplants.
Bookimed Expert Insight: Turkish transplantation centers demonstrate high technical proficiency by managing massive patient volumes. Medipol Mega and Hisar Hospital together serve over 1,500,000 patients yearly. This high frequency allows surgical teams to maintain peak clinical precision. Most top-rated hospitals are located in Istanbul, which simplifies logistics for international families.
Patient Consensus: Patients note that controlling the virus before surgery is essential for qualifying for a transplant. Reliable long-term monitoring and a solid plan for lifelong antiviral medicine are vital for preventing recurrence.